Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Malignant Ascites”

15 trials

Showing 15 of 15 results

Not applicableLooking for participantsNCT05726747
What this trial is testing

QOL and Sarcopenia in Patients With Ascites

Who this might be right for
Ascites HepaticAscites, Malignant
Abramson Cancer Center at Penn Medicine 70
Testing effectiveness (Phase 2)Ended earlyNCT02540356
What this trial is testing

Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer

Who this might be right for
Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites
Baxalta now part of Shire 2
Testing effectiveness (Phase 2)UnknownNCT05501340
What this trial is testing

PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites

Who this might be right for
Malignant Ascites
Second Affiliated Hospital of Soochow University 40
Not applicableUnknownNCT03550560
What this trial is testing

EUS-Guided Drainage of Refractory Malignant Ascites

Who this might be right for
Malignant Ascites
Hospital Universitario Virgen Macarena 100
Not applicableStudy completedNCT01532427
What this trial is testing

ALFApump System Post Marketing Surveillance Registry

Who this might be right for
Liver CirrhosisRefractory AscitesMalignant Ascites
Sequana Medical N.V. 100
Early research (Phase 1)Ended earlyNCT02496286
What this trial is testing

Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites

Who this might be right for
Malignant Ascites
Eastern Regional Medical Center 10
Early research (Phase 1)UnknownNCT05303844
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fudan University 25
Testing effectiveness (Phase 2)Ended earlyNCT00796861
What this trial is testing

Trial of Sunitinib for Refractory Malignant Ascites

Who this might be right for
Ascites
Milton S. Hershey Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT04771676
What this trial is testing

Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fudan University 25
Not applicableWithdrawnNCT02477657
What this trial is testing

Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology

Who this might be right for
Refractory Malignant Ascites
Abramson Cancer Center at Penn Medicine
Not applicableActive Not RecruitingNCT04326946
What this trial is testing

International Alfapump Cohort Study

Who this might be right for
Liver CirrhosesMalignant Ascites
Sequana Medical N.V. 400
Early research (Phase 1)UnknownNCT01852409
What this trial is testing

Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Peking University 18
Testing effectiveness (Phase 2)UnknownNCT03020979
What this trial is testing

A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites

Who this might be right for
Malignant AscitesApatinib
The First Affiliated Hospital of Bengbu Medical University 120
Early research (Phase 1)UnknownNCT05268172
What this trial is testing

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

Who this might be right for
Pleural Effusion, Malignant
Affiliated Hospital of Jiangnan University 40
Not applicableStudy completedNCT02891369
What this trial is testing

Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fondation Hôpital Saint-Joseph 30

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation